Clinical Trial Update: Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial of Velcade (bortezomib) plus cyclophosphamide in newly diagnosed multiple myeloma was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Velcade (bortezomib)

Snippet

Sponsor: Duke University | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2017-05-31